22 december, 2021 iCoat Medical receives approval from the Swedish MPA and starts its First in Human trial at Skåne University Hospital Läs mer
21 december, 2021 Communiqué from iCoat Medical’s (PUBL) extraordinary general meeting 15 December 2021 Läs mer
28 november, 2021 The European Union Intellectual Property Office grants iCoat Medical funding for IP assessment Läs mer
15 november, 2021 Carl Bjartmar is proposed as a new member to iCoat Medical’s Board of Directors Läs mer
24 juli, 2021 iCoat Medical has successfully raised 40 MSEK in a Pre-IPO to fund its upcoming First In Human-trial Läs mer